Notice of Intent to Sole Source – LabCorp
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | May 13, 2026 |
| Due Date: | May 20, 2016 |
| Solicitation No: | 26-005105 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: May 13, 2026 03:32 pm EDT
- Original Response Date: May 20, 2016 04:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Jun 04, 2016
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
-
NAICS Code:
- 339112 - Surgical and Medical Instrument Manufacturing
-
Place of Performance:
20892
This acquisition is for a one-year service contract for the Vantera Nuclear Magnetic Resonance analyzer currently used for patient care testing in the Clinical Center Department of Laboratory Medicine at the National Institutes of Health (NIH) Clinical Center (CC).
• Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies
• NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing
• Place of Performance: Bethesda, MD 20892 USA
POTS: 26-005105
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to Laboratory Corporation of America, located at 531 S Spring St, Burlington, NC 27215, on a firm fixed price sole source award basis to provide the one-year service contract to the National Institutes of Health.
LabCorp is the sole vendor and the only provider of service and support for the Vantera analyzer. The Vantera analyzer is used to perform lipoprotein particle quantification, including HDL, LDL, VLDL, average size measurements, and determination of small, medium, and large subfractions of each particle. There are currently no other commercial instruments, other than Vantera, which can perform this function.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by May 20, 2026 at 4pm EST.
- 6707 DEMOCRACY BLVD, SUITE 106
- BETHESDA , MD 20892
- USA
- Kristin Nagashima
- kristin.nagashima@nih.gov
- May 13, 2026 03:32 pm EDTSpecial Notice (Original)
See Also
Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.
VETERANS AFFAIRS, DEPARTMENT OF
Due by 9/17/2026
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 9/18/2026
Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 10/02/2026